Reaction
Infective Exacerbation Of Bronchiectasis reporting signals
As of the last recalculation, Infective Exacerbation Of Bronchiectasis appears in 290 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is TOBRAMYCIN (PRR 150.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tobramycin | 43 | 150.5 | 150.8 |
| Dornase Alfa | 30 | 122.4 | 122.6 |
| Amikacin | 24 | 110.0 | 110.2 |
| Lumacaftor And Ivacaftor | 12 | 104.8 | 104.9 |
| Tobramycin Solution | 14 | 87.8 | 87.9 |
| Tobramycin Sulfate | 14 | 85.2 | 85.3 |
| Methylprednisolone Acetate | 8 | 73.7 | 73.8 |
| Ivacaftor | 7 | 64.8 | 64.8 |
| Umeclidinium | 7 | 57.5 | 57.5 |
| Budesonide, Glycopyrrolate, And Formoterol Fumarate | 3 | 20.8 | 20.8 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 3 | 17.4 | 17.4 |